SOLNA, Sweden – 17 January, 2012 – Aerocrine AB (OMX Nordic Exchange: AERO) today announced that they have strengthened their medical team by adding former Teva R&D VP, Dr. Paul Dorinsky.  Paul joins Aerocrine as medical director, North America.
Paul is board certified in pulmonary and critical care medicine. He spent 15 years on faculty at The Ohio State University College of Medicine before joining the industry in 1997. Most recently, Dr. Dorinsky served as vice president, global respiratory R&D, at Teva Pharmaceuticals. He has also worked at Boehringer Ingelheim and GlaxoSmithKline, where he spent 10 years in various leadership positions in respiratory clinical development and medical affairs.

Based in the U.S., Dr. Dorinsky will have the responsibility of leading clinical development and medical affairs for North America. He will report directly to Kathy Rickard, M.D., chief medical officer.

“As a nationally recognized expert in pulmonary disease, Dr. Dorinsky brings...